← Open Payments lookup

GERALD MURPHY: Open Payments

NPI 1376562462 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$785 in 30 payments from 12 companies in 2025. Trend: 2023 $616 · 2024 $843 · 2025 $785

Food & beverage: $785
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$158
GlaxoSmithKline, LLC.6$149
PFIZER INC.3$86
Boehringer Ingelheim Pharmaceuticals, Inc.3$79
E.R. Squibb & Sons, L.L.C.2$75
Novo Nordisk Inc3$73
Lundbeck LLC2$49
ABBVIE INC.1$29
Lilly USA, LLC1$28
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$25

Products named: TRELEGY ELLIPTA, BREZTRI, ELIQUIS, JARDIANCE, AIRSUPRA, REXULTI, VYNDAQEL, QULIPTA.

Industry payments across CA — which companies pay providers there.